Angiotensin II for the Treatment of Vasodilatory Shock

Affiliations

¹ Cleveland Clinic Foundation, Cleveland, OH
² Guy’s and St. Thomas’ Hospital, London, United Kingdom
³ University of Melbourne, Melbourne, VIC, Australia rinaldo.bellomo@austin.org.au

Comment

Ashish Khanna et al. N Engl J Med. 2017.

. 2017 Dec 28;377(26):2604.

doi: 10.1056/NEJMc1714511.

¹ Cleveland Clinic Foundation, Cleveland, OH
² Guy’s and St. Thomas’ Hospital, London, United Kingdom
³ University of Melbourne, Melbourne, VIC, Australia rinaldo.bellomo@austin.org.au

No abstract available

Comment on

Angiotensin II for the Treatment of Vasodilatory Shock.
Gleeson PJ, Antonucci E. Gleeson PJ, et al. N Engl J Med. 2017 Dec 28;377(26):2601. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29281569 No abstract available.
Angiotensin II for the Treatment of Vasodilatory Shock.
Fouda R, Ammar H. Fouda R, et al. N Engl J Med. 2017 Dec 28;377(26):2601-2. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29282964 No abstract available.
Angiotensin II for the Treatment of Vasodilatory Shock.
Haeberle HA, Rosenberger P. Haeberle HA, et al. N Engl J Med. 2017 Dec 28;377(26):2602. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29282965 No abstract available.
Angiotensin II for the Treatment of Vasodilatory Shock.
Dünser MW, Meier J. Dünser MW, et al. N Engl J Med. 2017 Dec 28;377(26):2602-3. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29282966 No abstract available.
Angiotensin II for the Treatment of Vasodilatory Shock.
Jamme M, Hertig A, Rafat C. Jamme M, et al. N Engl J Med. 2017 Dec 28;377(26):2603. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29282967 No abstract available.
Angiotensin II for the Treatment of Vasodilatory Shock.
Janssens U. Janssens U. N Engl J Med. 2017 Dec 28;377(26):2603-4. doi: 10.1056/NEJMc1714511. N Engl J Med. 2017. PMID: 29282968 No abstract available.